GGrantIndex
Sort

40,608 grants matching prostate cancer

Stromal Regulation of Bone Metastasis

$1,129,443
Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA

Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy

$1,129,408
Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance

$1,129,373
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2021 · CA

Novel Translational Approaches to BPH/LUTS

$1,129,100
Robert H. Getzenberg · Johns Hopkins University · P50 · FY2009 · DK

Targeted Discovery of Marine-derived Anticancer Leads

$1,128,979
Phil Crews · University Of California Santa Cruz · U19 · FY2006 · CA

Telehealth Research and Innovation for Veterans with Cancer (THRIVE)

$1,128,603
Scott E Sherman · New York University School Of Medicine · P50 · FY2022 · CA

TRIBBLES 2, A NOVEL TARGET FOR THERAPY OF ENZALUTAMIDE-RESISTANT NEUROENDOCRINE PROSTATE CANCER

$1,128,417
Henry Ford Health System · · FY2022 · Defense Health Agency

CERAMIDE NANOLIPOSOMES AS A NOVEL THERAPEUTIC OPTION FOR LETHAL PROSTATE CANCER: EXPLOITING DE NOVO SPHINGOLIPID SYNTHESIS

$1,128,336
Rector & Visitors Of The University Of Virginia · · FY2022 · Department of the Army

Center for Interventional Oncology

$1,128,299
Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2016 · CA

Center of Excellence for Cancer Research, Training and Community Service

$1,127,952
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2014 · MD

Clinical Nursing and Data Management Core

$1,127,936
William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2016 · CA

Finding Genes for Human Prostate Cancer

$1,127,526
Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2015 · HG

Cancer Risk in Human Populations

$1,126,839
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA

PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE

$1,126,546
University Of North Carolina Chapel Hill · P01 · FY2000 · CA

Incorporating residential histories into assessment of cancer risk

$1,126,520
Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2025 · CA

OSTEOPOROTIC FRACTURES IN MEN (MR.OS)

$1,126,400
Oregon Health And Science University · U01 · FY2000 · AR

DEFINING AND MODULATING BRCANESS TO IMPROVE THE PRECISION OF PROSTATE CANCER THERAPY

$1,125,843
Fred Hutchinson Cancer Research Center · · FY2021 · Department of the Army

2021 PROSTATE CANCER CLINICAL CONSORTIUM CLINICAL RESEARCH SITE: UNIVERSITY OF WASHINGTON

$1,125,000
University Of Washington · · FY2022 · Defense Health Agency

Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic

$1,124,848
Aminah Jatoi · Mayo Clinic Rochester · K12 · FY2015 · CA

NOVEL THERAPEUTIC TARGETS FOR AGGRESSIVE PROSTATE CANCER IDENTIFIED THROUGH INDUCED PLURIPOTENT STEM CELL (IPSC) MODELING OF BRCA2MUT PROSTATE TISSUE

$1,124,825
The University Of Texas Health Science Center At San Antonio · · FY2024 · Defense Health Agency

Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent

$1,124,282
Eric Scott Bensen · Vergent Bioscience, Inc. · R44 · FY2022 · CA

SPORE in Prostate Cancer

$1,124,001
Michael M. Ittmann · Baylor College Of Medicine · P50 · FY2007 · CA

SBIR Phase II: A cloud-native, data-driven platform for automated quality assurance of radiation oncology treatment planning

$1,124,000
Michael R Bowers · Oncospace, Inc. · · FY2021 · TIP

Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein*

$1,123,992
Shaomeng Wang · University Of Michigan At Ann Arbor · U19 · FY2007 · CA

Determinants of Disparity in Prostate Cancer Outcomes

$1,123,687
Timothy R Rebbeck · University Of Pennsylvania · P50 · FY2009 · CA